[1] Yu X, Zhou Z, Hu D, et al. Pathogenic pseudorabies virus, China, 2012. Emerg Infect Dis, 2014; 20, 102−4. doi:  10.3201/eid2001.130531
[2] Mravak S, Bienzle U, Feldmeier H, et al. Pseudorabies in man. Lancet, 1987; 8531, 501−2.
[3] Ai JW, Weng SS, Cheng Q, et al. Human endophthalmitis caused by pseudorabies virus infection, China. 2017, Emerg Infect Dis, 2018; 24, 1087−10.
[4] Zhao WY, Li HF, Li SY, et al. Clinical experience and next-generation sequecing analysis of encephalitis caused by pseudotabies. Natl Med J China, 2018; 98, 1152−57.
[5] Ye XF, Wang HY, Fu SH, et al. Etiological spectrum of clinically diagnosed Japanese encephalitis cases reported in Guizhou province, China, in 2006. J of clini microbiol, 2010; 48, 1343−49. doi:  10.1128/JCM.01009-09
[6] Li X, Yang F, Hu X, et al. Two classes of protective antibodies against pseudorabies virus variant glycoprotein B: implications for vaccine design. PLoS Pathogens, 2017; 13, e1006777. doi:  10.1371/journal.ppat.1006777
[7] Dubot-Pérès A, Sengvilaipaseuth O, Chanthongthip A, et al. How many patients with anti-JEV IgM in cerebrospinal fluid really have Japanese encephalitis? Lancet Infect Dis, 2015; 15, 1376−7. doi:  10.1016/S1473-3099(15)00405-3
[8] Zheng L, Liu X, Yuan D, et al. Dynamic cerebrospinal fluid analyses of severe pseudorabies encephalitis. Transbound Emerg Dis, 2019; 66, 2562−5. doi:  10.1111/tbed.13297
[9] Yang H, Han H, Wang H, et al. A case of human viral encephalitis caused by pseudorabies virus infection in China. Front Neurol. 2019, 4z: 10: 534.
[10] Sun Y, Liang W, Liu Q, et al. Epidemiological and genetic characteristics of swine pseudorabies virus in mainland China between 2012 and 2017. Peer J, 2018; 23, e5785.